News
Author: Corporate Communication & Marketing / Korporatiewe Kommunikasie & Bemarking [Alec Basson]
Published: 27/05/2021
Researchers from ReSEP (Research on Socioeconomic Policy) in the Department of Economics at Stellenbosch University (SU) contributed significantly to Wave 4 of the
11 Working Papers that capture the findings of data collected for this wave of NIDS-CRAM which is a broadly nationally representative survey of the impacts of the COVID-19 pandemic on South Africans.
As part of NIDS-CRAM Wave 4, data on vaccines, employment, schooling, hunger, and early childhood development was collected between 2 February and 10 March this year and 5629 successful interviews were conducted. In a
Synthesis Report, the seven main findings are grouped in the following five categories: vaccines, education, employment, early childhood development and hunger. The findings are as follows:
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, UNITED STATES
Norwood, MA, May 25, 2021 (GLOBE NEWSWIRE) Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2021 Virtual Congress that will be taking place June 2-5, 2021.
Details of the presentations are as follows:
Presentation Title
: Phase 3 Trial of Lenabasum, a CB2 Agonist, for the Treatment of Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Session: Progress in myositis and scleroderma research - I
Below is
Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, the Senate Finance Committee discussed making permanent COVID-19 flexibilities, including those related to telehealth. See the hearing and other news below.
I.Regulations, Notices & Guidance
On May 19, 2021, the Food and Drug Administration (FDA) issued draft guidance entitled,
Feasibility Clinical Studies for Certain Medical Devices Intended to Therapeutically Improve Glycemic Control in Patients with Type 2 Diabetes Mellitus. The draft guidance provides recommendations for feasibility and early feasibility clinical studies for certain medical devices intended to therapeutically improve glycemic control in patients with Type 2 Diabetes Mellitus. These medical de
Experimental broadcast of whitewater river noise drives bats and birds away eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.